Invasive pneumococcal infections in children with asplenia

Keyphrases

• Invasive Pneumococcal Disease 100%
• Meningitis 100%
• Infections in children 100%
• Asplenia 100%
• S. Pneumoniae 80%
• Pneumonia Infection 60%
• Bacteremia 60%
• Congenital Asplenia 60%
• Non-susceptible 40%
• Splenectomy 40%
• Asplenic Patients 40%
• Survivors 20%
• Clinical Course 20%
• Clinical Presentation 20%
• Fever 20%
• Sinusitis 20%
• Children's Hospital 20%
• Shock 20%
• High Mortality 20%
• Antimicrobial Resistance 20%
• Pneumonia 20%
• Epidemiology 20%
• Clinical Disease 20%
• Streptococcus Pneumoniae 20%
• Respiratory Distress 20%
• Ceftriaxone 20%
• Penicillin 20%
• Osteomyelitis 20%
• Otitis Media 20%
• Fatal Outcome 20%
• Infection Risk 20%
• Multiple Episodes 20%
• Disseminated Intravascular Coagulation 20%
• Conjugate Pneumococcal Vaccine 20%
• Petechiae 20%
• Polysaccharide Pneumococcal Vaccine 20%
• Fulminates 20%
• Antimicrobial Prophylaxis 20%
• Unexplained Fever 20%
• Purpura 20%
• Conjugate Vaccine 20%
• Complex Congenital Heart Disease 20%

Medicine and Dentistry

• Pneumococcal Infection 100%
• Asplenia 100%
• Infection 75%
• Meningitis 62%
• Pneumococcus 50%
• Serotype 37%
• Bloodstream Infection 37%
• Diseases 25%
• Pneumococcus Vaccine 25%
• Splenectomy 25%
• Cohort Effect 12%
• Clinician 12%
• Disease Course 12%
• Pneumococcal Pneumonia 12%
• Streptococcus pneumonia 12%
• Sinusitis 12%
• Antiinfective Agent 12%
• Antibiotic Resistance 12%
• Polysaccharide 12%
• Respiratory Distress 12%
• Ceftriaxone 12%
• Penicillin 12%
• Osteomyelitis 12%
• Fatality 12%
• Cohort Analysis 12%
• Disseminated Intravascular Coagulation 12%
• Otitis Media 12%
• Punctate Hemorrhage 12%
• Purpura 12%
• Conjugate Vaccine 12%
• Complex Congenital Heart Disease 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Pneumococcal Infection 100%
• Asplenia 100%
• Infection 75%
• Meningitis 62%
• Bloodstream Infection 37%
• Diseases 25%
• Pneumococcus Vaccine 25%
• Disease Course 12%
• Streptococcus pneumonia 12%
• Sinusitis 12%
• Antiinfective Agent 12%
• Osteomyelitis 12%
• Penicillin 12%
• Ceftriaxone 12%
• Cohort Study 12%
• Fatality 12%
• Otitis Media 12%
• Polysaccharide 12%
• Disseminated Intravascular Clotting 12%
• Respiratory Distress 12%
• Conjugate Vaccine 12%
• Purpura 12%
• Congenital Heart Disease 12%
• Antibiotic Resistance 12%